Professional paper

Do hypertensive and diabetic patients also benefit from statin therapy?

Jernej Kos ; Krka, d.d., Novo mesto, Slovenia
Breda Barbič-Žagar orcid.org/0000-0002-1173-7361 ; Krka, d.d., Novo mesto, Slovenia
Mateja Grošelj ; Krka, d.d., Novo mesto, Slovenia

Abstract

The risk factors for cardiovascular diseases
(CVD) include hypertension, diabetes and dyslipidemia.
Therefore, the modern guidelines for CVD prevention suggest
several steps to reduce these risk factors, including pharmacological
treatment. Numerous clinical studies demonstrated
benefits of cholesterol level reduction in hypertensive patients.
It was shown that concomitant treatment of hypertension and
dyslipidemia significantly reduced CVD risk in comparison
with blood pressure or blood cholesterol reduction alone.
Clinical studies with Krka’s atorvastatin also demonstrated the
efficacy and safety of lipid-lowering therapy in hypertensive
patients with dyslipidemia. It is well known that the risk for
atherosclerotic cardiovascular disease in diabetic patients is
increased two to fourfold. Clinical studies demonstrated that
statin treatment was also beneficial in diabetic patients. Similarly,
sub-analyses of studies in diabetic patients treated with
Krka’s atorvastatin proved the advantages of such treatment, as
well as its safety. Thus, reducing high blood cholesterol levels
in hypertensive and diabetic patients clearly brings additional
benefits for the patients.

Keywords

atorvastatin; diabetes; hypertension; dyslipidemia

Hrčak ID:

71480

URI

https://hrcak.srce.hr/71480

Publication date:

16.6.2011.

Article data in other languages: croatian

Visits: 1.748 *